SIGNIFICANCE OF MYOCARDIAL TENASCIN-C EXPRESSION IN ASSOCIATION WITH INFILTRATIVE INFLAMMATORY CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY
Yasuo Sugano(keiyu Hospital), Toshihisa Anzai(Hokkaido University), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Hisao Ogawa(Kumamoto University Hospital), Takafumi Nakayama(National Cerebral and Cardiovascular Center), Tetsuro Yokokawa(Fukushima Medical University), Taka‐aki Matsuyama(National Cerebral and Cardiovascular Center), Hatsue Ishibashi‐Ueda(United Cerebral Palsy), Yoshihiko Ikeda(National Cerebral and Cardiovascular Center), Takeshi Nakatani(National Cerebral and Cardiovascular Center), Keiko Ohta‐Ogo(National Cerebral and Cardiovascular Center), Toshiyuki Nagai(Hokkaido University), Satoshi Yasuda(Tohoku University)
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755